{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:38:38Z","timestamp":1775263118775,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI Grant","award":["15H05291"],"award-info":[{"award-number":["15H05291"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214414","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T17:27:25Z","timestamp":1553880445000},"page":"e0214414","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical impact of endocapillary proliferation with modified cutoff points in IgA nephropathy patients"],"prefix":"10.1371","volume":"14","author":[{"given":"Ahmad Baseer","family":"Kaihan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotake","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"J V Donadio","year":"2002","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy.","author":"M Tatematsu","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/ajkd.2001.27689","article-title":"Predicting progression in IgA nephropathy","volume":"38","author":"LP Bartosik","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"ref4","first-page":"131","article-title":"IgA nephropathy in Korea: a morphological and clinical study","volume":"27","author":"HS Lee","year":"1987","journal-title":"Clin Nephrol"},{"key":"ref5","first-page":"45","article-title":"Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis","volume":"34","author":"E Alamartine","year":"1990","journal-title":"Clin Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"DC Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2215\/CJN.06530909","article-title":"Histopathologic features aid in predicting risk for progression of IgA nephropathy","volume":"5","author":"M Walsh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"H Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.2215\/CJN.02890311","article-title":"Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation","volume":"6","author":"R Katafuchi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10157-017-1393-x","article-title":"The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients","volume":"21","author":"AB Kaihan","year":"2017","journal-title":"Clin Exp Nephrol. Springer Japan"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ndt\/gfr295","article-title":"The Oxford classification as a predictor of prognosis in patients with IgA nephropathy","author":"SH Kang","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5812\/jnp.7","article-title":"Oxford-MEST classification in IgA nephropathy patients: A report from Iran","volume":"1","author":"H Nasri","year":"2012","journal-title":"J Nephropathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.humpath.2013.08.019","article-title":"Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy","volume":"45","author":"KS Park","year":"2014","journal-title":"Hum Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2369-13-158","article-title":"Validation of the Oxford classification of IgA nephropathy for pediatric patients from China","volume":"13","author":"W Le","year":"2012","journal-title":"BMC Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00467-011-2061-0","article-title":"Validity of the Oxford classification of IgA nephropathy in children","volume":"27","author":"Y Shima","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"ref16","first-page":"29","article-title":"Hong Kong J Nephrol","volume":"16","author":"H Kfoury","year":"2014"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5301\/jn.5000151","article-title":"A histologic classification of IgA nephropathy for predicting long-term prognosis: Emphasis on end-stage renal disease","volume":"26","author":"T Kawamura","year":"2013","journal-title":"J Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised Equations for Estimated GFR From Serum Creatinine in Japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: a randomised controlled trial","volume":"353","author":"C Pozzi","year":"1999","journal-title":"Lancet"},{"key":"ref20","first-page":"284","article-title":"Immunosuppressive therapy in patients with IgA nephropathy","author":"HPE Peters"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.V1081772","article-title":"The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial","volume":"10","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2369-15-94","article-title":"Long-term prognosis of clinically early IgA nephropathy is not always favorable","volume":"15","author":"H Lee","year":"2014","journal-title":"BMC Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility","volume":"76","author":"ISD Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"ref24","first-page":"269","article-title":"Estimation of youden index and its associated optimal cut-point when the parameters of gamma biomarkers are estimated by the method of moments","volume":"12","author":"M Stefan","year":"2011","journal-title":"Proc Rom Acad Ser A\u2014Math Phys Tech Sci Inf Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2215\/CJN.11521210","article-title":"Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: Validation of the Oxford classification","volume":"6","author":"SF Shi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref26","article-title":"The use of the oxford classification of IgA nephropathy to predict renal survival","author":"E Alamartine","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/pin.12442","article-title":"Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining","volume":"66","author":"G \u015etefan","year":"2016","journal-title":"Pathol Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1681\/ASN.V131142","article-title":"Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy","volume":"13","author":"FW Ballardie","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T21:14:06Z","timestamp":1663190046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214414"}},"subtitle":[],"editor":[{"given":"Xu-jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214414","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]}}}